The identification of diabetes-relevant islet autoantibodies is essential for predicting and preventing type 1 diabetes (T1D). The aim of the current study was to evaluate a newly developed ...

The researchers have also found a connection between enterovirus infection, the development of diabetes-related ...

Medically reviewed by Isabel Casimiro, MD, PhD Type 1.5 diabetes is a controversial diagnosis that combines features of the ...

A new study published in JSCAI has revealed a lower risk of cardiovascular events for patients with Type 1 diabetes (often ...

Type 1 diabetes — in which the immune system attacks pancreatic ... USA show that elimination of maternally transmitted islet β cell–reactive autoantibodies prevents diabetes in nonobese diabetic (NOD ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...

The cause of type 1 diabetes remains unknown and is a central focus of Boston College Assistant Professor of Biology Emrah Altindis and others in his field hoping to find new ways to help 1.6 million ...

A new study published in the Journal of the Society for Cardiovascular Angiography & Interventions has revealed a lower risk ...

SAB BIO, (“SAB BIO”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human ...

From the Diabetes ... 16.7 years (median 7.1 years) to clinical diabetes and all (n = 130) with persistent IAAs, GAD65, IA-2, and/or ZnT8. In addition, blindly coded Diabetes Autoantibody ...

In type 1 diabetes, antibodies from your immune system destroy the cells that produce insulin. The condition can start suddenly and is usually diagnosed in children. Type 2 diabetes most often ...